Abstract
Opinions on the ethics of using animal models of human disease to test novel pharmacological and other therapies are diverse [1]. We make no comment on whether animal experimentation as a concept is ‘ethical’, other than to note that animal (or ‘preclinical’) models of disease are currently considered mandatory in drug development, and only proceed if approved by institutional ethics boards which balance cost (to the animal) and benefit. The only rational approach to this situation is to make the most efficient use of this resource. This notion is codified in the internationally accepted principle of the “3Rs”: Replacement, reduction, and refinement (Table 1) [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Weatherall D (2007) Animal research: the debate continues. Lancet 369:1147–1148
Russell WMS, Burch RL (1959) The Principles of Humane Experimental Technique. Methuen & Co. Ltd, London
Angus DC, Mira JP, Vincent JL (2010) Improving clinical trials in the critically ill. Crit Care Med 38:527–532
Kochanek PM, Bramlett H, Dietrich WD et al (2011) A novel multicenter preclinical drug screening and biomarker consortium for experimental traumatic brain injury: operation brain trauma therapy. JTrauma 71:S15–S24
Fisher MM, Raftos J, McGuinness RT et al (1981) Funnel-web spider (Atrax robustus) antivenom. 2. Early clinical experience. Med J Aust 2:525–526
Vincent JL (2010) We should abandon randomized controlled trials in the intensive care unit. Crit Care Med 38:S534–S538
Bellomo R, Warrillow SJ, Reade MC (2009) Why we should be wary of single-center trials. Crit Care Med 37:3114–3119
Finfer S, Chittock DR, Su SY et al (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283–1297
Bellomo R, Cass A, Cole L et al (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361:1627–1638
Steinberg KP, Hudson LD, Goodman RB et al (2006) Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671–1684
Festing MF, Altman DG (2002) Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J 43:244–258
Macleod M (2011) Why animal research needs to improve. Nature 477:511
Kilkenny C, Parsons N, Kadyszewski E et al (2009) Survey of the quality of experimental design, statistical analysis and reporting of research using animals. PLoS One 4:e7824
Bebarta V, Luyten D, Heard K (2003) Emergency medicine animal research: does use of randomization and blinding affect the results? Acad Emerg Med 10:684–687
McCance I (1995) Assessment of statistical procedures used in papers in the Australian Veterinary Journal. Aust Vet J 72:322–328
Garner J, Watts S, Parry C, Bird J, Cooper G, Kirkman E (2010) Prolonged permissive hypotensive resuscitation is associated with poor outcome in primary blast injury with controlled hemorrhage. Ann Surg 251:1131–1139
Kirkman E, Watts S, Cooper G (2011) Blast injury research models. Philos Trans R Soc Lond B Biol Sci 366:144–159
Reynolds JC, Rittenberger JC, Menegazzi JJ (2007) Drug administration in animal studies of cardiac arrest does not reflect human clinical experience. Resuscitation 74:13–26
Smith III EF, Slivjak MJ, Egan JW, Gagnon R, Arleth AJ, Esser KM (1993) Fluid resuscitation improves survival of endotoxemic or septicemic rats: possible contribution of tumor necrosis factor. Pharmacology 46:254–267
Dyson A, Singer M (2009) Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Crit Care Med 37:S30–S37
Eichacker PQ, Parent C, Kalil A et al (2002) Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med 166:1197–1205
Turnbull IR, Wlzorek JJ, Osborne D, Hotchkiss RS, Coopersmith CM, Buchman TG (2003) Effects of age on mortality and antibiotic efficacy in cecal ligation and puncture. Shock 19:310–313
Kadioglu A, Cuppone AM, Trappetti C et al (2011) Sex-based differences in susceptibility to respiratory and systemic pneumococcal disease in mice. J Infect Dis 204:1971–1979
Reade MC, Milbrandt EB, Angus DC (2007) The impact of chronic disease on response to infection: more than just reduced physiological reserve? In: Vincent JL (ed) Yearbook of Intensive Care and Emergency Medicine. S**er, Heidelberg, pp 197–207
Haouzi P (2011) Murine models in critical care research. Crit Care Med 39:2290–2293
Center for Drug Evaluation and Research (1996) Guidance for industry: single dose acute toxicity testing for pharmaceuticals. Available at: http://www.fda.gov/downloads/Drugs/.../Guidances/ucm079270.pdf Accessed Oct 2012
Zbinden G (1993) The concept of multispecies testing in industrial toxicology. Regul Toxicol Pharmacol 17:85–94
Pusateri AE, Holcomb JB, Kheirabadi BS, Alam HB, Wade CE, Ryan KL (2006) Making sense of the preclinical literature on advanced hemostatic products. J Trauma 60:674–682
Sandercock P, Roberts I (2002) Systematic reviews of animal experiments. Lancet 360:586
Korevaar DA, Hooft L, ter Riet G (2011) Systematic reviews and meta-analyses of preclinical studies: publication bias in laboratory animal experiments. Lab Anim 45:225–230
Sena ES, van der Worp HB, Bath PM, Howells DW, Macleod MR (2010) Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol 8:e1000344
Perel P, Roberts I, Sena E et al (2007) Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ 334:197
Sung NS, Crowley Jr WF, Genel M et al (2003) Central challenges facing the national clinical research enterprise. JAMA 289:1278–1287
Kimmelman J, London AJ (2011) Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty. PLoS Med 8:e1001010
Eastwood D, Findlay L, Poole S et al (2010) Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells. Br J Pharmacol 161:512–526
Fisher Jr CJ, Agosti JM, Opal SM et al (1996) Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 334:1697–1702
Majde JA (2003) Animal models for hemorrhage and resuscitation research. J Trauma 54:S100–S105
Bath PM, Gray LJ, Bath AJ, Buchan A, Miyata T, Green AR (2009) Effects of NXY-059 in experimental stroke: an individual animal meta-analysis. Br J Pharmacol 157:1157–1171
Moher D, Hopewell S, Schulz KF et al (2010) CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 63:e1–e37
Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010) Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 8:e1000412
Hooijmans CR, Leenaars M, Ritskes-Hoitinga M (2010) A gold standard publication checklist to improve the quality of animal studies, to fully integrate the Three Rs, and to make systematic reviews more feasible. Altern Lab Anim 38:167–182
DeAngelis C, Drazen JM, Frizelle FA et al (2004) Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Med J Aust 181:293–294
Ross JS, Mulvey GK, Hines EM, Nissen SE, Krumholz HM (2009) Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med 6:e1000144
Prayle AP, Hurley MN, Smyth AR (2012) Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study. BMJ 344:d7373
Cochrane Injuries Group Albumin Reviewers (1998) Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 317:235–240
Cook DJ, Reeve BK, Guyatt GH et al (1996) Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA 275:308–314
Basso DM, Beattie MS, Bresnahan JC et al (1996) MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Multicenter Animal Spinal Cord Injury Study. JNeurotrauma 13:343–359
Regulation (EC) No1907/2006 of the European Parliament and of the Council of 18 December 2006, concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Agency, amending Directive 1999/45/EC and Repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93.67/EEC, 93/105/EC and 2000/21/EC. Available at http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2007:136:0003:0280:en:PDF Accessed Oct 2012
Dirnagl U, Fisher M (2012) International, multicenter randomized preclinical trials in translational stroke research: it’s time to act. J Cereb Blood Flow Metab 32:933–935
Bath PM, Macleod MR, Green AR (2009) Emulating multicentre clinical stroke trials: a new paradigm for studying novel interventions in experimental models of stroke. Int J Stroke 4:471–479
Acknowledgement:
We are grateful to Professor Rinaldo Bellomo both for planting the notion of multicenter, multispecies preclinical trials, and for driving the development of the ANZICS Clinical Trials Group, an effective demonstration of the value of multicenter collaborative research in critical care medicine.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Reade, M.C., Kirkman, E. (2013). Standardized Reporting, Registration, and a Multicenter, Multispecies Approach to Preclinical (Animal) Trials. In: Vincent, JL. (eds) Annual Update in Intensive Care and Emergency Medicine 2013. Annual Update in Intensive Care and Emergency Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-35109-9_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-35109-9_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-35108-2
Online ISBN: 978-3-642-35109-9
eBook Packages: MedicineMedicine (R0)